These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2012-003923-39 Pilot study to evaluate whether treating persistent small airway dysfunction with extra-fine HFA-Beclometasone results in improved asthma control. 2018-06-25 due-trials
Reported results Terminated 2012-005035-85 A proof of concept study in allergic rhinitis, to evaluate the differential effects of doxazosin between single and chronic dosing on nasal airway calibre 2015-06-02 due-trials
Reported results 2013-001103-36 Randomised controlled single and chronic dosing crossover comparison of extra fine particle formoterol and coarse particle salmeterol in asthmatic patients with persistent small airways dysfunction 2014-12-17 due-trials
Reported results 2013-001953-28 Proof of concept study to evaluate single and chronic dosing effects of ultra-long acting bronchodilator therapy on mannitol challenge in asthmatic patients taking inhaled corticosteroids 2016-07-15 due-trials
Reported results 2013-003594-99 Proof of Concept Evaluation of Drug-Device Interaction with aclidinium bromide via Genuair® and tiotropium bromide via HandiHaler® in COPD using Impulse Oscillometry 2015-07-09 due-trials
Reported results Terminated 2014-003455-61 Perindopril and Leucine to improve muscle function in older people 2020-01-15 due-trials
Reported results 2014-005317-23 Effects of ultra-long acting bronchodilator therapy assessed by impulse oscillometry in smoking asthmatics taking inhaled corticosteroids 2019-05-22 due-trials
Reported results Terminated 2015-001093-17 Proof of concept study to assess downstream effects of using combined intranasal fluticasone propionate plus azelastine nasal spray on asthmatic inflammation in patients with persistent asthma and all... 2018-09-10 due-trials
Other 2019-003763-22 A Pragmatic Proof of Concept Study to Evaluate the Effect of Benralizumab on Mannitol Challenge in Severe Eosinophilic Asthma not-yet-due